Insurers are projected to submit rate increases in the Affordable Care Act market of about 10 percent, which is higher than the roughly 6 percent increase for 2019, according to Dave Dillon, a fellow of the Society of Actuaries and senior vice president of Lewis & Ellis, Actuaries and Consultants.
A key part of the Trump administration’s plan to lower the list prices of drugs wouldn’t actually do so and would end up increasing federal spending by tens of billions of dollars over a decade, the Congressional Budget Office said Thursday.
Yesterday at the World Medical Innovation Forum in Boston, Centers for Medicare and Medicaid Services Administrator Seema Verma argued that government can often foil innovation.
The Trump administration’s plan to end legal protections for drug rebates in a move to curb costs would actually boost Part D premiums and federal spending, according to the Congressional Budget Office.
If The Senior Citizens League is correct in its forecasts — and it has a strong record of that — roughly half of the Social Security cost-of-living adjustment (COLA) for 2020 for the average retiree will be wiped out by the increase in Medicare Part B premiums that year.
More than 500 drugs saw price hikes at the beginning of 2019, including price increases of nearly 3% prices for generics, according to a new report. Researchers at GoodRx, an app and website that tracks drug pricing and offers coupons, found a 2.9% price hike across brand-name and generic drugs in the first quarter of 2019. Most of that was reported in the first week of January, when drugmakers often raise their prices, according to the report.